Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Julien G. Cohen"'
Autor:
Julien G. Cohen, Ludovic Broche, Mohammed Machichi, Gilbert R. Ferretti, Renaud Tamisier, Jean-Louis Pépin, Sam Bayat
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
BackgroundNasal high flow (NHF) is a non-invasive breathing therapy that is based on the delivery via a large-caliber nasal cannula of heated and humidified air at flow rates that exceed peak inspiratory flow. It is thought that positive airway press
Externí odkaz:
https://doaj.org/article/20d31d45a6d04e228f11a02e907e7925
Autor:
Herv O. Zender, Phaeton Angelloz-Pessey, Olivier Clerc, Gregor John, Julien G. Cohen, Jean-Marc Fellrath
Publikováno v:
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum.
Autor:
Herv O. Zender, Gregor John, Olivier Clerc, Julien G. Cohen, Phaeton Angelloz-Pessey, Jean-Marc Fellrath
Publikováno v:
Forum Médical Suisse ‒ Swiss Medical Forum.
Autor:
Julien G. Cohen, Ludovic Broche, Mohammed Machichi, Gilbert R. Ferretti, Renaud Tamisier, Jean-Louis Pépin, Sam Bayat
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
Frontiers in Physiology
Frontiers in Physiology, 2021, 12, pp.683316-1683316-7. ⟨10.3389/fphys.2021.683316⟩
'Frontiers in Physiology ', vol: 12, pages: 683316-1683316-7 (2021)
Frontiers in Physiology
Frontiers in Physiology, 2021, 12, pp.683316-1683316-7. ⟨10.3389/fphys.2021.683316⟩
'Frontiers in Physiology ', vol: 12, pages: 683316-1683316-7 (2021)
BackgroundNasal high flow (NHF) is a non-invasive breathing therapy that is based on the delivery via a large-caliber nasal cannula of heated and humidified air at flow rates that exceed peak inspiratory flow. It is thought that positive airway press
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6956010efae5ef960370d60a210c115
https://doi.org/10.21203/rs.3.rs-96171/v1
https://doi.org/10.21203/rs.3.rs-96171/v1
Autor:
Gilbert Ferretti, Adrien Jankowski, Maud Medici, Alexandre Moreau-Gaudry, François Laurent, Sylvie Lantuejoul, Mathieu Lederlin, Julien G. Cohen, E. Reymond, Anne-Claire Toffart
Publikováno v:
Diagnostic and Interventional Imaging
Diagnostic and Interventional Imaging, Elsevier, 2018, 99 (5), pp.291-299. ⟨10.1016/j.diii.2017.12.013⟩
Diagnostic and Interventional Imaging, Elsevier, 2018, 99 (5), pp.291-299. ⟨10.1016/j.diii.2017.12.013⟩
International audience; The purpose of this study was to evaluate the usefulness of computed tomography-texture analysis (CTTA) in differentiating between in-situ and minimally-invasive from invasive adenocarcinomas in subsolid lung nodules (SSLNs).M
Publikováno v:
Journal d'imagerie diagnostique et interventionnelle. 1:102-105
Publikováno v:
Journal d'imagerie diagnostique et interventionnelle. 1:S39-S44
Resume La prise en charge par le radiologue d’un patient presentant un nodule pulmonaire unique de decouverte fortuite est standardisee. Nous insisterons sur la technique d’acquisition tomodensitometrique (TDM), les reconstructions maximum intens
Autor:
Sylvie Lantuejoul, Gilbert Ferretti, Julien G. Cohen, F. Arbib, Adrien Jankowski, Elizabeth Brambilla, E. Reymond
Publikováno v:
Journal de Radiologie Diagnostique et Interventionnelle. 97:375-384
Resume L’adenocarcinome est la forme histologique la plus frequente de cancer bronchopulmonaire. Les nouvelles classifications des adenocarcinomes pulmonaires proposees recemment par l’International Association for the Study of Lung cancer, l’A
Autor:
Julien G. Cohen, Anthony Cole, Marie Ludwig, Gilbert Ferretti, E. Chipon, Maud Medici, Alexandre Moreau Gaudry, E. Reymond
Publikováno v:
BMJ Open
IntroductionLung cancer screening in individuals at risk has been recommended by various scientific institutions. One of the main concerns for CT screening is repeated radiation exposure, with the risk of inducing malignancies in healthy individuals.
Autor:
Julien G. Cohen, E. Reymond, M. Giaj-Levra, Gilbert Ferretti, A. Jankowski, Denis Moro-Sibilot, Anne-Claire Toffart
Publikováno v:
Revue des Maladies Respiratoires Actualités. 8:325-331
Resume De nouvelles therapeutiques personnalisees du cancer bronchique non a petites cellules, a la place ou association avec la chimiotherapie classique, sont utilisees en pratiques cliniques. Elles se repartissent en trois classes therapeutiques :